Monte Rosa Therapeutics, Inc. GLUE
- MRT-6160 Phase 1
- MRT-6160 — Sjögren's Syndrome Phase 2
VAV1 (2 companies · 3 programs)
Companies with an active program directed at VAV1.
Evommune, Inc. EVMN
- EVO570 — Rheumatoid Arthritis Preclinical
Companies with an active program directed at VAV1.